Suppr超能文献

需要连续性肾脏替代治疗的脓毒症急性肾损伤患者的氧化应激与“单核细胞重编程”

Oxidative stress and 'monocyte reprogramming' in septic patients with acute kidney injury requiring CRRT.

作者信息

Silva Sandra, de Cal Massimo, Cruz Dinna, Lentini Paolo, Corradi Valentina, Gallo Giampiero, Salvatori Gabriella, Verbine Anton, Pogoshyan Lusine, Nalesso Federico, Brendolan Alessandra, Piccinni Pasquale, Ronco Claudio

机构信息

Department of Nephrology, Dialysis and Transplant, St. Bortolo Hospital, Vicenza, Italy.

出版信息

Blood Purif. 2008;26(2):188-92. doi: 10.1159/000117308. Epub 2008 Feb 15.

Abstract

Oxidative stress (OS) and monocyte HLA-DR expression are known to be predictive of mortality in sepsis; nevertheless, limited information exists regarding sepsis with acute kidney injury (AKI). The aim of the study was to correlate these markers with outcome in septic patients with AKI requiring continuous renal replacement therapy (CRRT). Advanced oxidation protein products (AOPP) were measured in 32 patients on days 1, 3, 7, 14, 21, and 28. In 14 we assessed the percentage of monocytes expressing HLA-DR (%DR+) and the HLA-DR mean fluorescence intensity (MFI). 20 healthy volunteers, 17 septic patients without AKI and 20 septic AKI patients not treated by CRRT were used for comparison. The mortality rate was 59%. Septic CRRT patients had higher AOPP and lower %DR+ (p < 0.001, both) than healthy controls. They also had higher AOPP than septic patients who did not develop AKI (p < 0.001). No difference was found in AOPP, %DR+ and MFI between survivors and non-survivors (day 1 and subsequent measurements). No correlation was seen between severity scores and OS/HLA-DR. OS and HLA-DR expression are altered in septic patients with AKI undergoing CRRT. However, this study was not able to confirm the usefulness of these markers in predicting survival in this subset of patients.

摘要

已知氧化应激(OS)和单核细胞人类白细胞抗原-DR(HLA-DR)表达可预测脓毒症患者的死亡率;然而,关于合并急性肾损伤(AKI)的脓毒症的信息有限。本研究旨在将这些标志物与需要持续肾脏替代治疗(CRRT)的脓毒症合并AKI患者的预后相关联。对32例患者在第1、3、7、14、21和28天测量晚期氧化蛋白产物(AOPP)。对其中14例患者评估表达HLA-DR的单核细胞百分比(%DR+)和HLA-DR平均荧光强度(MFI)。使用20名健康志愿者、17例无AKI的脓毒症患者和20例未接受CRRT治疗的脓毒症合并AKI患者作为对照。死亡率为59%。脓毒症CRRT患者的AOPP高于健康对照,%DR+低于健康对照(均为p<0.001)。他们的AOPP也高于未发生AKI的脓毒症患者(p<0.001)。幸存者和非幸存者之间在AOPP、%DR+和MFI方面未发现差异(第1天及后续测量)。严重程度评分与OS/HLA-DR之间未发现相关性。接受CRRT的脓毒症合并AKI患者的OS和HLA-DR表达发生改变。然而,本研究未能证实这些标志物在预测该亚组患者生存方面的有用性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验